Using muscle bath techniques, we examined the inhibitory activities of several E-and F-ring isoprostanes in canine and porcine airway smooth muscle. 8-Isoprostaglandin E1 and 8-isoprostaglandin E2 (8-iso PGE2) reversed cholinergic tone in a concentration-dependent manner, whereas the F-ring isoprostanes were ineffective. Desensitization with 8-iso-PGE2 and PGE2 implicated isoprostane activity at the PGE2 receptor (EP). We found that the inhibitory E-ring isoprostane responses were significantly augmented by rolipram (a type IV phosphodiesterase inhibitor), while 1H-[1,2,4]-oxadiazolo[4,3-a]quinoxalin-1-one (a guanylate cyclase inhibitor) had no effect, suggesting a role for cAMP in isoprostane-mediated relaxations. 8-Iso-PGE2 did not reverse KCl tone, suggesting that voltagedependent Ca 2ϩ influx and myosin light chain kinase are not suppressed by isoprostanes. Patch-clamp studies showed marked suppression of K ϩ currents by 8-iso-PGE2. We conclude that E-ring isoprostanes exert PGE2 receptor-directed, cAMP-dependent relaxations in canine and porcine airway smooth muscle. This activity is not dependent on K ϩ channel activation or the direct inhibition of voltage-operated Ca 2ϩ influx or myosin light chain kinase. cyclic nucleotides; potassium channels; calcium channels; prostanoid receptors IT HAS BEEN SUGGESTED THAT the bronchodilatory and contractile effects of free radicals in airways are mediated by isoprostanes (9), a large family of prostaglandin (PG)-like molecules, produced in a cyclooxygenase-independent manner via free radical-mediated peroxidation of the membrane phospholipid arachidonic acid (22-25). These molecules, which differ from PGs in the cis orientation of their side chains at the cyclopentane ring junction, are present at levels in the nanomolar range in normal human plasma and urine (23). Isoprostanes are present in even higher concentrations during periods of oxidative stress (20, 21, 23, 27) , in such diseases as asthma (18), cystic fibrosis (19), chronic obstructive pulmonary disorder (17), and atherosclerosis (33), and may contribute to the pathology of these diseases (13, 23, 28) .
IT HAS BEEN SUGGESTED THAT the bronchodilatory and contractile effects of free radicals in airways are mediated by isoprostanes (9) , a large family of prostaglandin (PG)-like molecules, produced in a cyclooxygenase-independent manner via free radical-mediated peroxidation of the membrane phospholipid arachidonic acid (22) (23) (24) (25) . These molecules, which differ from PGs in the cis orientation of their side chains at the cyclopentane ring junction, are present at levels in the nanomolar range in normal human plasma and urine (23) . Isoprostanes are present in even higher concentrations during periods of oxidative stress (20, 21, 23, 27) , in such diseases as asthma (18) , cystic fibrosis (19) , chronic obstructive pulmonary disorder (17) , and atherosclerosis (33) , and may contribute to the pathology of these diseases (13, 23, 28) .
Researchers have only recently begun to demonstrate the biological responses elicited by isoprostanes in many tissue types. Most research has focused solely on the excitatory activity of 8-iso-PGF 2␣ , a vasoconstrictor (16, 28, 40) , bronchoconstrictor (9, 13) , and inhibitor of platelet aggregation (26) .
Very little is known about the signaling pathways or receptors through which inhibitory isoprostanes act. It has been suggested that isoprostanes may act via prostanoid receptors (4, 37) ; isoprostanes and prostanoids differ only in the orientation of their side chain, thus allowing for many similar binding interactions with receptor active site residues (1, 38) .
The prostanoid receptors are categorized as follows: DP, EP, FP, IP, and TP receptors, one each for the five principal metabolites PGD 2 , PGE 2 , PGF 2␣ , PGI 2 , and thromboxane A 2 , respectively (with each receptor having an affinity of Ն1 order of magnitude greater for one prostanoid over the other four) (2, 29) . The EP receptor can be further subdivided into the EP 1 , EP 2 , EP 3 , and EP 4 subtypes, all of which bind PGE 2 with high affinity but differ with regard to physiological activity and/or the signaling pathway induced (29) . Evidence supporting subtypes of the EP 1 , EP 3 , FP, and TP receptors exists as well (7, 15, 32) .
There is evidence to support 8-iso-PGF 2␣ acting as an agonist at the vascular TP receptors (16, 28, 40) while conversely acting antagonistically at platelet TP receptors to inhibit aggregation (26). 8-Iso-PGE 2 may act at the TP receptor as well in renal vasculature (25) . There are also studies that support a role for the FP (39) and the EP prostanoid receptors (34, 38, 39) in excitatory 8-iso-PGE 2 activity. It has also been argued that isoprostanes may exert their effects through their own unique class of receptor (28) .
Previously, we communicated the effects of seven different isoprostanes on airway smooth muscle, including the first description of relaxations evoked by E-ring isoprostanes (9) . The aim of this study was to further enhance the present knowledge of isoprostanes and their inhibitory physiological responses. For this purpose, canine and porcine bronchial smooth muscle was used to examine the relaxant effects of several Eand F-ring isoprostanes as well as the signaling pathway(s) underlying these relaxations. Initial studies were also performed to assess the possibility that the relaxant isoprostanes act through the classic relaxant prostanoid receptors IP, DP, EP 2 , and EP 4 .
METHODS
Tissue preparation. Adult mongrel dogs were euthanized with pentobarbital sodium (100 mg/kg), and lobes of lungs were excised; pig lungs were obtained from an abattoir. Trachea and lungs were placed in ice-cold Krebs solution (see Solutions and chemicals) and secured with dissection pins. The bronchus was carefully dissected by removal of the overlying connective tissue and pulmonary vasculature. Tracheal smooth muscle strips (ϳ1 mm wide) and bronchial ring segments (3-5 mm OD, ϳ2-5 mm long) were excised and used immediately or stored at 4°C for use up to 48 h later.
Muscle bath studies. Tracheal strips and bronchial smooth muscle ring segments were hung in 4-ml baths. The tracheal strips were tied with silk thread (Ethicon 4-0), such that one end of the strip was anchored, while the other was fastened to a Grass FT.03 force transducer. Hooks inserted through the lumen, one of which was anchored and the other fastened to the transducer, were used to hang the bronchial rings. Changes in isometric force were digitized (at 2 Hz) and recorded on-line using the DigiMed System Integrator program (MicroMed, Louisville, KY).
Protocol. Tissues were maintained in Krebs buffer containing 10 Ϫ5 M indomethacin (to prevent formation of endogenous PGs, which could cause relaxation), gassed with 95% O2-5% CO2 to give a final pH of 7.4, and maintained at 37°C. Preload tension was applied and kept between 1.0 and 1.5 g (optimal resting tension) to ensure maximal physiological responses. Tissues were equilibrated for 1 h, during which time they were repeatedly washed with Krebs buffer. To establish a reference contraction for standardization of contractile responses and to ensure tissue responsiveness, tissues were challenged with 60 mM KCl. The KCl was then washed out, and tissues were allowed to recover before the experiments were begun. Tissues were exposed to 10 Ϫ6 M ICI-192605, a TP prostanoid receptor blocker, Ն15 min before isoprostane additions to inhibit excitatory activities of the isoprostanes at this receptor (9) . Relaxant responses were studied in tissues precontracted with the cholinergic agonist carbachol (CCh) or KCl. Once tone stabilized, cumulative concentration-relaxation response relationships were evaluated for the various isoprostanes. All inhibitors {rolipram, atropine, propranolol, and 1H-[1,2,4]-oxadiazolo[4,3-a]quinoxalin-1-one (ODQ)} were added Ն20 min before addition of precontractile agonist to allow establishment of inhibitory activity.
Patch-clamp studies. Tracheal tissues were minced, transferred to dissociation buffer containing collagenase (Sigma blend F; 0.9 U/ml) and elastase (type IV, 12.5 U/ml), incubated at 37°C for 1 h, and then gently triturated to liberate individual myocytes. These were allowed to settle and adhere to the bottom of a recording chamber (1 ml volume) and superfused with standard Ringer solution at room temperature. Electrophysiological responses were tested in cells that were phase dense and appeared relaxed. Recordings were made using the nystatin perforated-patch configuration of the conventional patch-clamp recording technique (8) and pipettes with tip resistances of 3-5 M⍀ when filled with electrode solution. Membrane currents were filtered at 5 kHz and sampled at 2 Hz. Acquisition and analysis of data were accomplished using Axopatch 200B and pCLAMP8 software (Axon Instruments, Foster City, CA).
Solutions and chemicals. The Krebs buffer consisted of 116 mM NaCl, 4.6 mM KCl, 2.5 mM CaCl2, 1.3 mM NaH2PO4, 1.2 mM MgSO4, 23 mM NaHCO3, 11 mM D-glucose, and 10 Ϫ5 M indomethacin bubbled to maintain pH 7.4. The composition of the dissociation buffer was as follows (mM): 125 NaCl, 5 KCl, 1 CaCl 2, 1 MgCl2, 10 HEPES, 0.25 EDTA, 10 D-glucose, and 10 L-taurine (pH 7.0). The composition of the electrode solution was as follows: 140 mM KCl, 1 mM MgCl 2, 0.4 mM CaCl2, 20 mM HEPES, 1 mM EGTA, and 150 U/ml nystatin (pH 7.2). The composition of Ringer buffer was as follows (mM): 130 NaCl, 5 KCl, 1 CaCl 2, 1 MgCl2, 20 HEPES, and 10 D-glucose (pH 7.4). The isoprostanes were dissolved in ethanol, with the exception of 8-iso-PGF 3␣, which was dissolved in methyl acetate; these stock solutions were then diluted with Krebs buffer. Aqueous dilutions were discarded after 24 h. ODQ, S-nitroso-N-acetylpenicillamine (SNAP), rolipram, and ICI-192605 were dissolved in DMSO. All other compounds were dissolved in Krebs buffer. The isoprostanes and PGE 2 were obtained from Cayman Chemical (Ann Arbor, MI) and rolipram from Research Biochemicals. Cicaprost, iloprost, and BW-245C were gifts from Dr. Denis Crankshaw (McMaster University). All other chemicals were obtained from Sigma Chemical.
Data analysis. Relaxations were expressed as percent reversal of precontractile tone (minus preload tone). The concentration at which 50% reversal of tone was achieved ([R 50] values) was interpolated from the concentration-response relationships. The Ϫlog [R 50] value (in M) is used to express the potency of the drug; %R is used to describe the percentage of relaxation evoked for the highest drug concentration used (i.e., the maximal response); n is the number of animals used.
Values are means Ϯ SE. One-way ANOVA and Student's t-test were used to ascertain the statistical significance of differences between mean values.
RESULTS

Relaxant responses to isoprostanes in canine and
porcine bronchial smooth muscle. Cumulative concentration-response relationships were investigated for various E-and F-ring isoprostanes (Fig. 1) . In canine and porcine tissues, 8-iso-PGF 1␣ , 8-iso-PGF 2␣ , and 8-iso-PGF 2␤ had little or no effect on cholinergic tone. (Fig. 2B) . The cost of these compounds prevented us from testing at Ͼ10 Ϫ5 M. Receptor identity. It has been suggested that isoprostanes may act via the classic prostanoid receptors (4, 37), three of which, DP, IP, and EP (EP 2 and EP 4 subtypes), are generally inhibitory in smooth muscle. We first sought to ascertain which inhibitory prostanoid receptors are present in canine bronchial tissue. Cumulative concentration-response relationships were investigated using the receptor-selective agonists cicaprost and iloprost (IP selective), BW-245C (DP selective), and PGE 2 (EP selective, but does not distinguish between EP 2 and EP 4 ). The DP-selective agonist exerted only minor reversal (25 Ϯ 6%) of cholinergic tone at 10 Ϫ5 M (Fig. 3) , whereas the IP-selective agonists were somewhat more efficacious, their effects beginning in the submicromolar range, but still reversed cholinergic tone by Ͻ50% at the highest concentration tested (%R ϭ 51 Ϯ 8% for cicaprost and 37 Ϯ 4% for iloprost). The EP-selective agonist, however, markedly reversed tone (%R ϭ 76 Ϯ 13% at 10 Ϫ5 M), with Ϫlog [R 50 ] estimated to be 6.4 Ϯ 0.1 M. These results indicate that the inhibitory prostanoid receptors in canine bronchi are predominantly of the EP type.
Before assessing the role of the EP receptors in isoprostane-mediated inhibitory responses, we ascer- (Fig. 4) . We conclude that activation of the M 2 receptor by CCh antagonizes the activity of 8-iso-PGE 2 (likely via inhibition of adenylate cyclase).
Next, we addressed whether the responses to 8-iso-PGE 2 are mediated through the EP receptors. Unfortunately, highly selective antagonists for the inhibitory EP receptor subtypes (EP 2 and EP 4 ) are not readily available. We therefore investigated the effects of desensitizing the tissues to PGE 2 on 8-iso-PGE 2 -induced relaxations and vice versa. Tissues were exposed to a high concentration of PGE 2 or 8-iso-PGE 2 (10 Ϫ5 M) for 3 h before assessment of the concentration-response profiles for these two agonists, as well as isoproterenol. AFDX-116 (10 Ϫ6 M) was added near the end of the desensitization period for 20 min, and the tissues were washed with CCh (7 ϫ 10 Ϫ7 M)-supplemented Krebs solution (to remove the desensitizing agent). After 15 min, during which time cholinergic tone became reasonably stable, the responses to PGE 2 , 8-iso-PGE 2 , and isoproterenol were compared.
The data are summarized in Fig. 5 . After the tissues were desensitized to 8-iso-PGE 2 , responses to the isoprostane and the PG were reduced by as much as 45 and 64% for 8-iso-PGE 2 (10 Ϫ5 M) and PGE 2 (10 Ϫ7 M), respectively, whereas the isoproterenol response was essentially unaltered. Similarly, desensitization with PGE 2 resulted in marked suppression of responses to PGE 2 (79% at 10 Ϫ7 M) and 8-iso-PGE 2 (37% at 10 Ϫ5 M), but not to isoproterenol. The lack of desensitization in the case of isoproterenol, which does not induce EP receptor activity, indicates that the attenuation of PGE 2 -and 8-iso-PGE 2 -induced relaxations was due to homologous desensitization.
Equieffective concentrations of the isoprostane and prostanoid were used in similar but limited studies on canine bronchial smooth muscle. After the tissues were desensitized to 8-iso-PGE 2 , responses to 8-iso-PGE 2 (10 Ϫ5 M) and PGE 2 (10 Ϫ6 M) decreased equivalently (40 and 39%, respectively; Table 1 ). Similarly, after the tissues were desensitized with PGE 2 , both responses were reduced to a similar degree (30 and 37%, respectively; Table 1 ). These results are consistent with 8-iso-PGE 2 acting at an EP receptor.
Role of cyclic nucleotides. The EP 2 and EP 4 receptors generally couple to the G s protein to induce adenylate cyclase activity, resulting in increased cAMP levels and subsequent activation of protein kinase A, which in turn phosphorylates various targets, leading to smooth muscle relaxation (14, 29) . cAMP can also cause elevation of cGMP levels by various means, leading to powerful relaxations (31) . We therefore investigated the role of cAMP vs. cGMP in isoprostane-induced relaxations.
The effects of ODQ, an inhibitor of soluble guanylate cyclase, on 8-iso-PGE 2 -and SNAP-evoked responses were compared. ODQ had essentially no effect on 8-iso-PGE 2 -induced reversal of tone evoked by 10 Ϫ7 M CCh, whereas SNAP-induced relaxations were abolished (Fig. 6) . We conclude that guanylate cyclase plays little or no role in 8-iso-PGE 2 -induced relaxations. To ascertain the involvement of cAMP in these relaxations, we examined relaxations evoked by 8-iso-PGE 2 (in canine tissues preconstricted with 10 Ϫ7 M CCh) and 8-iso-PGE 1 (in porcine tissues preconstricted with 3 ϫ 10 Ϫ7 M CCh) in the presence or absence of the cAMPdependent phosphodiesterase inhibitor rolipram (type IV phosphodiesterase blocker, 10 Ϫ5 M). Rolipram significantly augmented the relaxations at 10 Ϫ5 and 10
Ϫ6
M for 8-iso-PGE 1 and at 10 Ϫ6 M for 8-iso-PGE 2 (Fig. 7) . These data suggest that cAMP may play a role in the signaling pathway activated by the isoprostanes. 
Inhibition of Ca
2ϩ channels or myosin light chain kinase. Relaxant agonists may act by inhibiting Ca 2ϩ influx and/or suppressing myosin light chain kinase (MLCK) activity (36) . To test whether isoprostanes exert either of these effects, we used tissues preconstricted with KCl (60 mM), which evokes contractions that are entirely dependent on both of these processes. Tissues were pretreated with atropine and propranolol to eliminate the contributions of cholinergic and adrenergic nerves stimulated by KCl. 8-Iso-PGE 2 did not substantially reverse KCl tone, inducing Ͻ15% relaxation, compared with the complete reversal of tone in matching tissues preconstricted with 10 Ϫ7 M CCh (Fig.  8) . The relative lack of effect of the isoprostane on KCl-evoked tone indicates that 8-iso-PGE 2 Figure 9A shows representative traces of currents evoked using depolarizing step commands from a holding potential of Ϫ60 mV; the current-voltage relationship is given in Fig. 9B . 8-Iso-PGE 2 (10 Ϫ5 M) in the application pipette caused a marked suppression of these K ϩ currents: on average, currents evoked by pulses to ϩ10 mV were reduced 72 Ϯ 13% (n ϭ 8). Clearly, then, isoprostanes do not mediate their relaxant effects via activation of K ϩ channels.
DISCUSSION
Researchers have only begun to characterize the biological effects of isoprostanes. Most studies of isoprostane-elicited responses have focused solely on the Values are means Ϯ SE, expressed as percent reversal of cholinergic tone (6 ϫ 10 Ϫ7 M); n, number of animals. PGE2, prostaglandin E2. Control tissues did not undergo desensitization. * Significantly different from control. Fig. 5 . 8-Iso-PGE2 appears to act via EP receptors. In porcine tracheal tissue, relaxations were evoked by 8-iso-PGE2 (A), PGE2 (B), or isoproterenol (C) in control tissues and in tissues that had been desensitized to 8-iso-PGE2 or PGE2. Relaxations are expressed as percent reversal of tone evoked by 7 ϫ 10 Ϫ7 M CCh. All tissues were exposed to 10 Ϫ6 M AFDX-116 (n ϭ 4-6). * Significantly different from control.
excitatory activity of 8-iso-PGF 2␣ on various types of tissues. Only recently has attention been focused on their potential inhibitory effects.
Previously, we reported the effects of seven different isoprostanes on airway smooth muscle, including the first description of relaxations evoked by E-ring isoprostanes (9) . The results of this study demonstrate that 8-iso-PGE 1 and 8-iso-PGE 2 induce relaxations in canine and porcine bronchial smooth muscle with similar potencies, whereas F-ring isoprostanes are relatively ineffective in this respect. E-ring isoprostaneinduced relaxations were conserved in epitheliumdenuded porcine tracheal tissues as well as in N-nitro-L-arginine-and indomethacin-treated, epitheliumintact bronchial tissues (data not shown). This finding is consistent with isoprostanes acting directly on smooth muscle tissues, although a role for epitheliumderived relaxant mediators cannot be entirely discounted.
Isoprostanes and prostanoids share a similar structure, differing only in the orientation of their side chains; thus it is reasonable to assume that they are capable of forming similar binding interactions with receptor active site residues (23) . Indeed, Breyer (1) and Ungrin et al. (38) shed some light on the structural features of PGE 2 required for binding to the EP 1 prostanoid receptor, including the hydroxyl group on the cyclopentane ring and the side chain, both of which are present on the isoprostanes tested in this study. There is evidence to support 8-iso-PGF 2␣ (16, 26, 28, 40 ) and 8-iso-PGE 2 (25) activity at the TP prostanoid receptor. There are also studies supporting the role of FP (39) and EP excitatory prostanoid receptors (34, 38, 39) in 8-iso-PGE 2 activity. On the other hand, others argue for the existence of a unique class of isoprostane receptors (28) .
The EP 2 prostanoid receptor, along with the IP and, to a lesser extent, the DP receptor, is known to be involved in human bronchial smooth muscle relax- quinoxalin-1-one (ODQ) had no effect on concentration-relaxation relationship for 8-iso-PGE2 but essentially abolished that for S-nitroso-N-acetylpenicillamine (SNAP, A and B, respectively; n ϭ 4 for both). * Significantly different from control.
ations, whereas EP 4 is not (30) . EP 2 was also shown to mediate airway smooth muscle relaxations in mice (6, 35) . Our data suggest that IP and DP receptors are largely unimportant with respect to prostanoid relaxations in canine bronchial tissue, since only partial responses to the IP-and DP-selective agonists are seen and only at relatively high concentrations. Instead, these IP-and DP-selective agonists may be exerting nonspecific actions at inhibitory EP receptors, which are present and are likely to be involved in isoprostaneinduced relaxations, as was demonstrated using receptor desensitization techniques. Using this approach, we determined that PGE 2 desensitization of the 8-iso-PGE 2 response and vice versa were due to homologous desensitization, inasmuch as neither 8-iso-PGE 2 nor PGE 2 induced heterologous desensitization of the isoproterenol response.
The EP 2 and EP 4 receptors couple to the G s protein to induce adenylate cyclase activity, resulting in increased cAMP levels (14, 29) . Inhibition of type IV phosphodiesterase activity with rolipram enhanced the relaxations to 8-iso-PGE 1 and 8-iso-PGE 2 in porcine and canine tissues. These results suggest that the two E-ring isoprostanes may induce relaxations through the accumulation of cAMP and that type IV phosphodiesterase opposes this. Further studies involving the inhibition of adenylate cyclase and protein kinase A would lend additional support to this conclusion. In contrast, the guanylate cyclase inhibitor ODQ had no effect on 8-iso-PGE 2 -induced relaxations, thus ruling out the involvement of cGMP in these responses. -dependent K ϩ channels (3, (10) (11) (12) . We tested this directly using patch-clamp techniques and found that K ϩ currents were rapidly and markedly suppressed by isoprostanes.
Other signaling pathways by which isoprostanes might exert a relaxant effect include 1) inhibition of the Rho A-Rho kinase pathway, which increases the Ca 2ϩ sensitivity of the contractile apparatus by inhibiting myosin light chain phosphatase, 2) inhibition of the phosphoinositide pathway, which increases cytosolic Ca 2ϩ by activating sarcoplasmic reticulum inositol trisphosphate Ca 2ϩ channels, 3) activation of sarcoplasmic/endoplasmic reticulum Ca 2ϩ -ATPase, which decreases cytosolic Ca 2ϩ , or 4) activation of myosin light chain phosphatase, which dephosphorylates and deactivates myosin. Most of the experiments in this study involved the use of CCh, a cholinergic agonist that acts at the M 2 and M 3 muscarinic receptors present on airway smooth muscle to induce contraction. Activation of M 3 receptors leads to the induction of phosphoinositide turnover, whereas M 2 receptor activation results in the inhibition of adenylate cyclase and thus a decreased level of cAMP. Because inhibitory isoprostanes appear to act through induction of adenylate cyclase activity, the use of CCh as the precontractile agent confounds the results, leading to an attenuation of isoprostaneinduced relaxation. We have demonstrated that this functional antagonism could be overcome using the M 2 receptor-selective inhibitor AFDX-116.
Isoprostanes are present in the nanomolar range in normal human plasma (23) and increase up to 100-to 200-fold during periods of oxidative stress, which characterize a variety of disease states (20, 21, 23, 27) . The physiological responses of isoprostanes commence in the submicromolar range and are thus clinically relevant. Therefore, a better understanding of the mechanisms of action of isoprostanes may provide further insight into the pathology of oxidative stress.
In conclusion, it was found that 8-iso-PGE 2 and 8-iso-PGE 1 induce relaxations in canine and porcine bronchial smooth muscle, likely because of activity at the EP prostanoid receptor. The relaxant responses to the E-ring compounds appear to be mediated by the second messenger cAMP. Although the downstream effector(s) is unclear, we have ruled out activation of K ϩ channels and have evidence to suggest that there is no direct inhibition of voltage-gated Ca 2ϩ channels or of MLCK.
